BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 27821544)

  • 1. Phosphate and Vitamin D Prevent Periodontitis in X-Linked Hypophosphatemia.
    Biosse Duplan M; Coyac BR; Bardet C; Zadikian C; Rothenbuhler A; Kamenicky P; Briot K; Linglart A; Chaussain C
    J Dent Res; 2017 Apr; 96(4):388-395. PubMed ID: 27821544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-specific mineralization defects in the periodontium of the Hyp mouse model of X-linked hypophosphatemia.
    Coyac BR; Falgayrac G; Baroukh B; Slimani L; Sadoine J; Penel G; Biosse-Duplan M; Schinke T; Linglart A; McKee MD; Chaussain C; Bardet C
    Bone; 2017 Oct; 103():334-346. PubMed ID: 28764922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contributions of increased osteopontin and hypophosphatemia to dentoalveolar defects in osteomalacic Hyp mice.
    Mohamed FF; Hoac B; Phanrungsuwan A; Tan MH; Giovani PA; Ghiba S; Murshed M; Foster BL; McKee MD
    Bone; 2023 Nov; 176():116886. PubMed ID: 37634682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dentoalveolar Defects in the
    Zhang H; Chavez MB; Kolli TN; Tan MH; Fong H; Chu EY; Li Y; Ren X; Watanabe K; Kim DG; Foster BL
    J Dent Res; 2020 Apr; 99(4):419-428. PubMed ID: 31977267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Craniofacial and dental characteristics of patients with vitamin-D-dependent rickets type 1A compared to controls and patients with X-linked hypophosphatemia.
    Gjørup H; Beck-Nielsen SS; Haubek D
    Clin Oral Investig; 2018 Mar; 22(2):745-755. PubMed ID: 28608052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of X-linked hypophosphatemia in adults.
    Lecoq AL; Brandi ML; Linglart A; Kamenický P
    Metabolism; 2020 Feb; 103S():154049. PubMed ID: 31863781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conventional Therapy in Adults With X-Linked Hypophosphatemia: Effects on Enthesopathy and Dental Disease.
    Connor J; Olear EA; Insogna KL; Katz L; Baker S; Kaur R; Simpson CA; Sterpka J; Dubrow R; Zhang JH; Carpenter TO
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3625-32. PubMed ID: 26176801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease Manifestations and Complications in Dutch X-Linked Hypophosphatemia Patients.
    Bosman A; Appelman-Dijkstra NM; Boot AM; de Borst MH; van de Ven AC; de Jongh RT; Bökenkamp A; van den Bergh JP; van der Eerden BCJ; Zillikens MC
    Calcif Tissue Int; 2024 Mar; 114(3):255-266. PubMed ID: 38226986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of bone material properties in adult patients with X-linked hypophosphatemia (XLH).
    Fratzl-Zelman N; Gamsjaeger S; Blouin S; Kocijan R; Plasenzotti P; Rokidi S; Nawrot-Wawrzyniak K; Roetzer K; Uyanik G; Haeusler G; Shane E; Cohen A; Klaushofer K; Paschalis EP; Roschger P; Fratzl P; Zwerina J; Zwettler E
    J Struct Biol; 2020 Sep; 211(3):107556. PubMed ID: 32619592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-linked hypophosphatemia: Management and treatment prospects.
    Lambert AS; Zhukouskaya V; Rothenbuhler A; Linglart A
    Joint Bone Spine; 2019 Nov; 86(6):731-738. PubMed ID: 30711691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-Linked Familial Hypophosphatemia: A Case Report of 27-Year Old Male and Review of Literature.
    Abdullah SJ; Mahwi TO; Mohamad Salih Saeed A; Abdulateef DS; Rahman HS; Ahmed SF; Abdulqader SA
    Horm Metab Res; 2023 Oct; 55(10):653-664. PubMed ID: 37813097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dental impact of anti-fibroblast growth factor 23 therapy in X-linked hypophosphatemia.
    Lira Dos Santos EJ; Nakajima K; Po J; Hanai A; Zhukouskaya V; Biosse Duplan M; Linglart A; Shimada T; Chaussain C; Bardet C
    Int J Oral Sci; 2023 Dec; 15(1):53. PubMed ID: 38052774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-FGF-23 neutralizing antibodies ameliorate muscle weakness and decreased spontaneous movement of Hyp mice.
    Aono Y; Hasegawa H; Yamazaki Y; Shimada T; Fujita T; Yamashita T; Fukumoto S
    J Bone Miner Res; 2011 Apr; 26(4):803-10. PubMed ID: 20939065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron replacement ameliorates hypophosphatemia in autosomal dominant hypophosphatemic rickets: A review of the role of iron.
    Menon LP; Weinstein RS
    Bone; 2020 Feb; 131():115137. PubMed ID: 31756522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Active Vitamin D or FGF23 Antibody on
    Lira Dos Santos EJ; Chavez MB; Tan MH; Mohamed FF; Kolli TN; Foster BL; Liu ES
    J Dent Res; 2021 Dec; 100(13):1482-1491. PubMed ID: 33906518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sclerostin antibody improves alveolar bone quality in the Hyp mouse model of X-linked hypophosphatemia (XLH).
    Carpenter KA; Alkhatib DO; Dulion BA; Guirado E; Patel S; Chen Y; George A; Ross RD
    Int J Oral Sci; 2023 Oct; 15(1):47. PubMed ID: 37813865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Oral Health Status in Chilean Patients with X-Linked Hypophosphatemia.
    Marin A; Morales P; Jiménez M; Borja E; Ivanovic-Zuvic D; Collins MT; Florenzano P
    Calcif Tissue Int; 2021 Aug; 109(2):132-138. PubMed ID: 33839802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone Volumetric Density, Microarchitecture, and Estimated Bone Strength in Tumor-Induced Rickets/Osteomalacia
    Jiajue R; Ni X; Jin C; Yu W; Huo L; Wu H; Liu Y; Jin J; Lv W; Zhou L; Xia Y; Chi Y; Cui L; Pang Q; Li X; Jiang Y; Wang O; Li M; Xing X; Meng X; Xia W
    Front Endocrinol (Lausanne); 2022; 13():883981. PubMed ID: 35769089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired mineral quality in dentin in X-linked hypophosphatemia.
    Coyac BR; Falgayrac G; Penel G; Schmitt A; Schinke T; Linglart A; McKee MD; Chaussain C; Bardet C
    Connect Tissue Res; 2018 Dec; 59(sup1):91-96. PubMed ID: 29745817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis.
    Insogna KL; Briot K; Imel EA; Kamenický P; Ruppe MD; Portale AA; Weber T; Pitukcheewanont P; Cheong HI; Jan de Beur S; Imanishi Y; Ito N; Lachmann RH; Tanaka H; Perwad F; Zhang L; Chen CY; Theodore-Oklota C; Mealiffe M; San Martin J; Carpenter TO;
    J Bone Miner Res; 2018 Aug; 33(8):1383-1393. PubMed ID: 29947083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.